Skip to main content
Year archive

Grand Pharmaceutical Group Limited — 2020 filings

All 50 regulatory filings released by Grand Pharmaceutical Group Limited (512) in 2020, sourced directly from the official regulator.

50 Filings
2020 Period
2020 filings (50)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT: FIRST PATIENT DOSED IN THE PHASE 1B CLINICAL TRIAL FOR SEPSIS OF THE GROUP WORLD-CLASS INNOVATIVE DRUG STC3141
Regulatory Filings
2020-12-13 English
VOLUNTARY ANNOUNCEMENT: SIRTEX ENTERED INTO INVESTMENT AND COOPERATION AGREEMENT WITH NANOSPECTRA BIOSCIENCES, INC. AND SIRTEX ENTERED INTO SHARES PURCHASE AGREEMENT WITH BLACKSWAN VASCULAR, INC.
Capital/Financing Update
2020-12-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2020
Share Issue/Capital Change
2020-12-02 English
VOLUNTARY ANNOUNCEMENT: THE GROUP AND BELGUIM BASED ETHERNA ENTERED INTO EXCLUSIVE STRATEGIC COOPERATION AND LICENSING AGREEMENT ON WORLD-CLASS INNOVATIVE PRODUCTS IN GREATER CHINA REGION
Capital/Financing Update
2020-11-29 English
VOLUNTARY ANNOUNCEMENT: ENTERED INTO COOPERATIVE FRAMEWORK AGREEMENT ON RADIATION SAFETY AND ENVIRONMENTAL PROTECTION WITH NUCLEAR AND RADIATION SAFETY CENTER OF THE MINISTRY OF ECOLOGY AND ENVIRONMEN
Regulatory Filings
2020-11-26 English
VOLUNTARY ANNOUNCEMENT: NDA FOR PROSTATE CANCER IMAGING PRODUCT TLX591-CDX WAS ACCEPTED BY FDA
Regulatory Filings
2020-11-25 English
VOLUNTARY ANNOUNCEMENT: NDA FOR SIR-SPHERES Y-90 RESIN MICROSPHERES WAS ACCEPTED BY NMPA
Regulatory Filings
2020-11-25 English
VOLUNTARY ANNOUNCEMENT: Interim Data of TAVO from Registration-enabled Clinical Trial for Treatment of Resistant Metastatic Melanoma Achieved Much Higher than Primary Efficacy Endpoint
Regulatory Filings
2020-11-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2020
Share Issue/Capital Change
2020-11-03 English
VOLUNTARY ANNOUNCEMENT: APPRVOAL FROM FDA FOR COVID-19 VACCINE CORVAX12 TO CONDUCT PHASE I CLINICAL TRIAL
Regulatory Filings
2020-11-03 English
VOLUNTARY ANNOUNCEMENT: Entered into Subscription Agreement, Exclusive Licensing and Commercial Partnership Agreement with Telix&#x3b; Entered into Memorandum of Strategic Cooperation with Jiangsu Ins
Capital/Financing Update
2020-11-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2020
Share Issue/Capital Change
2020-10-06 English
INTERIM REPORT 2020
Regulatory Filings
2020-09-17 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2020
Regulatory Filings
2020-09-01 English
VOLUNTARY ANNOUNCEMENT - SIR-SPHERES Y-90 RESIN MICROSPHERES WAS APPROVED TO FILE NEW DRUG APPLICATION BASED ON CLINICAL RESULTS OBTAINED OVERSEAS
Regulatory Filings
2020-08-18 English
Next Day Disclosure Return
Regulatory Filings
2020-08-10 English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2020-08-10 English
2020 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report
2020-08-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2020
Regulatory Filings
2020-08-04 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2020-08-02 English
DATE OF BOARD MEETING
Regulatory Filings
2020-07-29 English
CONNECTED TRANSACTION: PROPOSED CAPITAL SUBSCRIPTION AND ACQUISITION OF THE EQUITY INTEREST IN THE TARGET COMPANY AND PROPOSED CAPITAL CONTRIBUTION TO THE FUND
Capital/Financing Update
2020-07-27 English
THE GROUP ENTERED INTO MAJOR TERMS FOR THE PRODUCTION AND GLOBAL COMMERCIALIZATION RIGHTS OF A WORLD-WIDE INNOVATIVE VESICULAR STOMATITIS VIRUS PRODUCT AND SUBSCRIPTION OF SHARES OF A COMPANY
Capital/Financing Update
2020-07-14 English
CONTINUING CONNECTED TRANSACTIONS: SUPPLEMENTAL ANNOUNCEMENT
Regulatory Filings
2020-07-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2020
Share Issue/Capital Change
2020-07-03 English
CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings
2020-06-30 English
CONNECTED TRANSACTION: INVESTMENT IN A FUND
Capital/Financing Update
2020-06-22 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 19 JUNE 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-19 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2020
Share Issue/Capital Change
2020-06-02 English
VOLUNTARY ANNOUNCEMENT: CAPITAL INVESTMENT IN ETHERNA IN BELGIUM AND ESTABLISH EXCLUSIVE STRATEGIC COOPERATION IN GREATER CHINA
Capital/Financing Update
2020-05-31 English
Notice of Annual General Meeting
AGM Information
2020-05-15 English
Proxy form for the annual general meeting to be held on 19 June 2020 or any adjournment thereof
AGM Information
2020-05-15 English
General Mandate to Repurchase Shares and Issue New Shares&#x3b; Re-Election of Retiring Directors&#x3b; Re-Appointment of Auditor&#x3b; and Notice of Annual General Meeting
Proxy Solicitation & Information Statement
2020-05-15 English
Annual Report 2019
Annual Report
2020-05-15 English
FURTHER ANNOUNCEMENT ON AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Audit Report / Information
2020-05-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2020
Share Issue/Capital Change
2020-05-06 English
VOLUNTARY ANNOUNCEMENT: THE GROUP'S WORLD-WIDE INNOVATIVE DRUG STC3141 GOR APPROVAL FOR PHASE II CLINICAL RESEARCH ON COVID-19 ARDS AND PHASE IB CLINICAL RESEARCH ON SEPSIS
Regulatory Filings
2020-05-06 English
VOLUNTARY ANNOUNCEMENT: FURTHER SUBSCRIPTION OF SHARES IN AN ASSOCIATED COMPANY
Capital/Financing Update
2020-05-04 English
VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE FOR THE FIRST DRUG COATED BALLOON SPECIFIED FOR VASCULAR ACCESS FOR HEMODIALYSIS IN THE PRC MARKET
Regulatory Filings
2020-04-20 English
VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED THE DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF A NEW DRUG FOR PTERYGIUM AND SUBSCRIPTION OF SHARES OF A COMPANY
Regulatory Filings
2020-04-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2020
Regulatory Filings
2020-04-03 English
ANNOUNCEMENT OF UNAUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Annual Report
2020-03-27 English
VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED THE DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF A WORLD-WIDE FIRST DEVELOPED DRUG FOR SEPSIS
Capital/Financing Update
2020-03-22 English
DATE OF BOARD MEETING
Regulatory Filings
2020-03-17 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2020
Share Issue/Capital Change
2020-03-05 English
POSITIVE PROFIT ALERT
Earnings Release
2020-02-23 English
VOLUNTARY ANNOUNCEMENT: COMPLETION OF PURCHASE OF SHARES OF ONCOSEC MEDICAL INCORPORATED AND EFFECTIVENESS OF EXCLUSIVE COMMERCIAL RIGHTS OF THE LICENSED PRODUCTS IN THE LICENSED TERRITORIES
Capital/Financing Update
2020-02-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2020
Regulatory Filings
2020-02-06 English
VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED THE DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF A NEW DRUG FOR DRY EYE SYNDROME AND WILL SUBSCRIBE SHARES IN A TAIWAN COMPANY
Capital/Financing Update
2020-01-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2019
Share Issue/Capital Change
2020-01-03 English